USPTO GRANTS TWO PATENTS TO CELEXION

摘要

Bioengineering company Celexion was granted two patents by the US Patent and Trademark Office (USPTO), bringing its total number of patents to eight. All of the company's patents relate to metabolic engineering and the production of renewable chemicals enabling the construction of genomesized DNA constructs as well as the production of valuable petrochemicals from renewable sources.